Qingdao university, University in Qingdao, China

The COVID-19 vaccine made by China's Sinopharm was less effective than others at preventing infection, hospitalization and death, according to a new study.A report published by The Wall Street Journal stated that this study, conducted by the kingdom of Bahrain and Columbia University researchers, especially holds true among people over 50.This comes as Chinese vaccines have become a major factor in Beijing's diplomacy manoeuvres, especially in developing countries with fewer resources.The WSJ report stated that despite high levels of inoculation with the Sinopharm vaccine, Bahrain in May started giving booster shots to vulnerable citizens using a different shot made by Pfizer Inc. and BioNTech SE. "It now also offers booster shots for other vaccines," the report added.According to the study, all the vaccines administered since December in Bahrain--which also include Covishield, and the Russian-made Sputnik V--were effective in combatting the virus compared to the unvaccinated population.Dr Jaleela Al-Sayed Jawad, co-author of the study said researchers found that there is a "significant difference" between hospitalization, ICU admission and death in favour of Pfizer compared to Sinopharm, especially in older populations. The study also stands true in the context of the emergence of the Delta variant.Last month, reports had emerged that China plans to use an mRNA vaccine, co-developed by China's Fosun Pharma and Germany's BioNTech, as a booster shot for those already vaccinated in the country using other Chinese vaccines.Despite giving over 1 billion doses of COVID-19 vaccine, it has no plans to relax its border restrictions until at least 2022, The Diplomat reported. Most of the citizens have received vaccines made by Sinovac and Sinopharm Group. Both these vaccines use inactivated particles of the virus, rather than the newer mRNA technology."Chinese authorities plan to use the vaccine, which goes by the brand name Comirnaty, as a booster shot for people who have received inactivated-virus vaccines, people close to regulators told Caixin," according to The Diplomat's report citing Chinese media outlet Caixin.( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Qingdao UniversityFOLLOW

Qingdao university, Latest News

New Delhi, Aug 31 Global growth rebound has solidified, but spread of delta variant poses risks, Moody's Investors ... ...

Binoy Viswam, Communist Party of India (CPI) Rajya Sabha MP from Kerala has raised objection over the new course in Jawaharlal Nehru University (JNU) which lists "jihadi terror" and terms the Soviet Union and China "sponsors of terrorism". ...

Indian shooting contingent's brilliant run continued on Day 7 of the Tokyo Paralympics as shooters Manish Narwal and Singhraj Adana qualified for the medal round in the Men's 10m Air Pistol SH1, here at the Asaka Shooting Range on Tuesday. ...

Tokyo, Aug 31 Archer Rakesh Kumar's campaign in the Men's Individual Compound Open came to an end as ... ...

Beijing, Aug 31 Short-form video app TikTok's parent company Founded in 2015, Pico claims to have more than ... ...

Targeting Prime Minister Narendra Modi on the China issue, All India Majlis-e-Ittehadul Muslimeen (AIMIM) chief Asaduddin Owaisi on Monday alleged that the PM is afraid to take the name of the country even though it has occupied Indian territory. ...

Indian shooter Swaroop Mahavir Unhlakar finished on the fourth position in the men's R1 -- 10m Air Rifle standing SH1 final event at the Asaka Shooting Range on Monday. ...

The COVID-19 vaccine made by China's Sinopharm was less effective than others at preventing infection, hospitalization and death, according to a new study. ...